Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current WST market cap is 23.13B. The company's latest EPS is USD 8.1936 and P/E is 38.98.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 748.8M | 731.4M | 695.4M | 704.9M | 749M |
| Operating Income | 184.1M | 163.6M | 124.6M | 131.6M | 166.6M |
| Net Income | 161.3M | 137M | 115.3M | 111.3M | 136M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.85B | 2.15B | 2.83B | 2.89B | 2.95B |
| Operating Income | 297.6M | 405.4M | 750.9M | 728.4M | 702.6M |
| Net Income | 241.7M | 346.2M | 661.8M | 585.9M | 593.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.75B | 3.83B | 3.6B | 3.49B | 3.68B |
| Total Liabilities | 886.5M | 948.5M | 921.7M | 912.6M | 923M |
| Total Equity | 2.87B | 2.88B | 2.68B | 2.58B | 2.75B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.34B | 2.79B | 3.31B | 3.62B | 3.83B |
| Total Liabilities | 768.2M | 939.3M | 978.4M | 931.9M | 948.5M |
| Total Equity | 1.57B | 1.85B | 2.34B | 2.68B | 2.88B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 537.4M | 776.5M | 118.2M | 283.2M | 463.3M |
| Investing | -259.9M | -368.7M | -90.6M | -191.8M | -273.9M |
| Financing | -270.1M | -459.6M | -271M | -489.3M | -553.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 367.2M | 472.5M | 584M | 724M | 776.5M |
| Investing | -228M | -179.5M | -253.1M | -288.2M | -368.7M |
| Financing | -36.8M | -137.1M | -168.1M | -293.6M | -459.6M |
| Market Cap | 23.13B |
| Price to Earnings Ratio | 38.98 |
| Price to Sales Ratio | 7.83 |
| Price to Cash Ratio | 27.09 |
| Price to Book Ratio | 8.03 |
| Dividend Yield | 0.26% |
| Shares Outstanding | 72.42M |
| Average Volume (1 week) | 582.05k |
| Average Volume (1 Month) | 670.71k |
| 52 Week Change | -9.87% |
| 52 Week High | 413.70 |
| 52 Week Low | 265.00 |
| Spread (Intraday) | 57.18 (17%) |
| Company Name | West Pharmaceutical Services Inc |
| Address |
530 herman o. west drive exton, pennsylvania 19341 0645 |
| Website | https://www.westpharma.com |
| Industry | fabricated rubber pds, nec (3060) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
